부산대학교 도서관

Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. behnam_nabet@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. behnam_nabet@dfci.harvard.edu.; Ferguson FM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mohardt ML; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Robichaud A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Buckley DL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Lu DY; Harvard/MIT MD-PhD Program, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ellegast JM; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ross KN; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Malone CF; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lin S; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Mabe NW; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dharia NV; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Meyer A; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Conway A; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Su AH; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Selich-Anderson J; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Taslim C; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Byrum AK; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Seong BKA; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Adane B; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Rivera MN; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.; Lessnick SL; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Division of Pediatric Hematology, Oncology and BMT, The Ohio State University College of Medicine, Columbus, OH, USA.; Stegmaier K; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Kimberly_Stegmaier@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. Kimberly_Stegmaier@dfci.harvard.edu.

Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

Ladumor Y; Department of Medical Biophysics, University of Toronto, Toronto, Canada.; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Seong BKA; Department of Medical Biophysics, University of Toronto, Toronto, Canada.; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Hallett R; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Neurosciences and Mental Health Programs, Hospital for Sick Children, Toronto, Canada.; Valencia-Sama I; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Adderley T; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Wang Y; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Kee L; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Gont A; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Kaplan DR; Neurosciences and Mental Health Programs, Hospital for Sick Children, Toronto, Canada.; Department of Molecular Genetics and University of Toronto, Toronto, Canada.; Irwin MS; Department of Medical Biophysics, University of Toronto, Toronto, Canada.; Cell Biology, Hospital for Sick Children, Toronto, Canada.; Department of Pediatrics, University of Toronto, Toronto, Canada.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Larrue C; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Scheidegger NK; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kuljanin M; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wechsler CS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; Kugener G; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; Mashaka T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mouche S; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Adane B; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Younger ST; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Piccioni F; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Lee LH; Division of Oncology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Wunderlich M; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Letai A; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tamburini J; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts. Kimberly_stegmaier@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Jiang B; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.; Jiang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.; Kaltheuner IH; Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Iniguez AB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; The Broad Institute, Cambridge, MA, 02142, USA.; Anand K; Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Ferguson FM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.; Ficarro SB; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; The Broad Institute, Cambridge, MA, 02142, USA.; Greifenberg AK; Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Dust S; Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Kwiatkowski NP; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.; Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; The Broad Institute, Cambridge, MA, 02142, USA.; Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.; Geyer M; Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA. Electronic address: nathanael_gray@dfci.harvard.edu.

Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Chong S; Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA; Howard Hughes Medical Institute, University of California, Berkeley, CA, USA.; Robichaud A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Conway A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hamze A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ross L; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Adane B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Ferguson FM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Stolte B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Dr.von Hauner Children's Hospital, Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany.; Wang EJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sun J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Darzacq X; Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA; CIRM Center of Excellence, University of California, Berkeley, CA, USA.; Piccioni F; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. Electronic address: kimberly_stegmaier@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Crowdis J; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Conway JR; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Alimohamed S; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina.; Haas BJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Han K; Department of Genetics, Stanford University School of Medicine, Stanford, California.; Park J; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dietlein F; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; He MX; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Imamovic A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ma C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bassik MC; Department of Genetics, Stanford University School of Medicine, Stanford, California.; Program in Cancer Biology, Stanford University School of Medicine, Stanford, California.; Program in Chemistry, Engineering and Medicine for Human Health (ChEM-H), Stanford University, Stanford, California.; Boehm JS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Vazquez F; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Liu D; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; McFarland JM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Van Allen EM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts. eliezerm_vanallen@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Adane B; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Alexe G; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Bioinformatics Graduate Program, Boston University, Boston, MA, USA.; Seong BKA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lu D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Hwang EE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Hnisz D; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.; Lareau CA; Department of Pathology, Stanford University, Stanford, CA, USA.; Ross L; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Lin S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Dela Cruz FS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Richardson M; Department of Pathology, Dalhousie University, Halifax, NS, Canada.; Weintraub AS; Whitehead Institute for Biomedical Research, Cambridge, MA, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Wang S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Iniguez AB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Dharia NV; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Conway AS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Robichaud AL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Tanenbaum B; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Krill-Burger JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Vazquez F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Schenone M; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Berman JN; Department of Pediatrics and Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.; Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Aryee MJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, Charlestown, MA, USA.; Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: briand_crompton@dfci.harvard.edu.; Stegmaier K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: kimberly_stegmaier@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

법학논문집 41. 1 (2017): 69-105.

Alshareef A; Department of Applied Medical Sciences, Taibah University, Medina, Saudi Arabia.; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.; Irwin MS; Division of Haematology-Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada.; Gupta N; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.; Zhang HF; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.; Haque M; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.; Findlay SD; Department of Oncology, University of Alberta, Edmonton, Canada.; Department of Anatomy and Cell Biology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Canada.; Seong BKA; Department of Medical Biophysics, University of Toronto, Toronto, Canada.; Lai J; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.; Rayis M; Department of Pediatric Oncology, King Fahad Medical City, Riyadh, Saudi Arabia.; Al-Dandan S; Department of Anatomical Pathology, King Fahad Medical City, King Saud bin Abdulaziz University, Riyadh, Saudi Arabia.; Lai R; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.; Department of Oncology, University of Alberta, Edmonton, Canada.; DynaLIFE Medical Laboratories, Edmonton, Canada.

Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

Lee, Sun-Young; Ahn, Ji-Hyun; Ko, Kyoung Won; Kim, Jaetaek; Jeong, Seong Whan; Kim, In-Kyung; Kim, Jin; Kim, Ho-Shik

Prostaglandins & Other Lipid Mediators. Feb2010, Vol. 91 Issue 1/2, p30-37. 8p.